CBD hemp online store is extracted from cannabis plants like hemp and marijuana. CBD, however, does not produce the psychoactive effects that make you feel “high” or intoxicated. This is because CBD and THC (tetrahydrocannabinol) act differently on different receptors in the brain and body.
THC binds with the cannabinoid 1 (CB1) receptors in the brain, which affects memory, thinking, concentration, movement, coordination, and sensory and time perception.
CBD binds very weakly, if at all, to CB1 receptors. In fact, it can actually block the binding of THC and dampen the psychoactive effects. CBD is thought to produce its own therapeutic effects by binding to cannabinoid 2 (CB2) receptors in the body.
CB2 receptors are found mostly in the immune system, and they seem to reduce inflammation and certain types of pain. Binding of CBD to CB2 receptors may also contribute to its anti-inflammatory and pain-relieving effects.
CBD does not contain THC, the psychoactive compound in cannabis that causes a high. However, CBD does appear to produce significant changes in the body, and some research suggests it has medical benefits.
CBD oil has shown promise as a treatment for both depression and anxiety, leading many who live with these disorders to become interested in this natural approach.
In one Brazilian study, 57 men received either oral CBD or a placebo 90 minutes before they underwent a simulated public speaking test. The researchers found that a 300-mg dose of CBD was the most effective at significantly reducing anxiety during the test.
The placebo, a 150-mg dose of CBD, and a 600-mg dose of CBD had little to no effect on anxiety. CBD oil has also been used to safely treat insomnia and anxiety in children with post-traumatic stress disorder (13Trusted Source).
Another study gave 214 people with severe epilepsy 0.9–2.3 grams of CBD oil per pound (2–5 g/kg) of body weight. Their seizures reduced by a median of 36.5% (27Trusted Source).
One more study found that CBD oil significantly reduced seizure activity in children with Dravet syndrome, a complex childhood epilepsy disorder, compared to a placebo (28Trusted Source).